Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi
CorePharma's Generic Clorazepate Dipotassium Receives Approval in the U.S.
The Italian Ministry of Health has banned compounding pharmacies from preparing drugs containing any of seven APIs after chemists were discovered making dangerous off-label weight loss treatments.
Market Place
Share
Share
